U.S. Senators Press Mylan To Explain 400-Percent Cost Increase For EpiPen Pack
Sen. Chuck Grassley, R-Iowa, wrote to Mylan Laboratories requesting the company's pricing data while Sen. Amy Klobuchar, D-Minn., asked the Federal Trade Commission and Senate Judiciary Committee to investigate the price hikes.
The New York Times:
Congress Presses Pharmaceutical Company To Explain Surge In Cost Of EpiPen
It’s back-to-school time — as well as campaign season — and lawmakers are becoming increasingly focused on the growing cost of pens: EpiPens, that is. Members of Congress are expressing rising alarm about the increasing costs of the lifesaving injection device for people with severe allergies, and they are hearing from anxious parents. (Hulse, 8/23)
Stat:
Senators Press Mylan Labs Over 'Outrageous' EpiPen Pricing
Responding to the high cost of the EpiPen auto-injector for reversing life-threatening allergic reactions, Senator Chuck Grassley (R-Iowa), who chairs the Senate Judiciary Committee, on Monday wrote Mylan Laboratories asking for pricing data on the device. At the same time, Senator Amy Klobuchar (D-Minn.) asked the US Federal Trade Commission and the Senate Judiciary Committee to investigate price hikes taken by Mylan. Klobuchar happens to be the ranking member of Senate Judiciary Antitrust Subcommittee. And Senator Richard Blumenthal (D-Conn.) also wrote the company for data about assistance programs to patients and first responders. And he also demanded that Mylan lower its price. (Silverman, 8/22)
Reuters:
U.S. Lawmakers Press Mylan On EpiPen Price Increases
Two senior lawmakers on the U.S. Senate's Judiciary Committee on Monday pushed for information regarding sharp price increases for EpiPens, drug-filled injectable devices used by people to counter potentially deadly allergic reactions. (Bartz, 8/22)
The Hill:
Grassley Presses EpiPen Maker On 400 Percent Price Increase
Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) is asking the maker of EpiPens to explain sharp increases in the device's price. Grassley wrote a letter to Mylan, the company that makes EpiPens, asking for an explanation of a 400 percent increase in the price since 2007. (Sullivan, 8/22)